AMT vs GERN · P/E 31, rev $10.64B vs rev $109.3M
American Tower Corp (AMT) versus Geron Corporation (GERN) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Geron Corporation (GERN) is a biotechnology company listed on US.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. GERN currently screens at market cap $878.9M.
Not investment advice. Open the AMT and GERN stock pages for the full models.
Not investment advice.